IBDEI11P ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18431,1,4,0)
 ;;=4^CMP OTH HYPERTROPHIC
 ;;^UTILITY(U,$J,358.3,18431,1,5,0)
 ;;=5^425.18
 ;;^UTILITY(U,$J,358.3,18431,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,18432,0)
 ;;=425.4^^102^1181^6
 ;;^UTILITY(U,$J,358.3,18432,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18432,1,4,0)
 ;;=4^CMP OTH PRIMARY
 ;;^UTILITY(U,$J,358.3,18432,1,5,0)
 ;;=5^425.4
 ;;^UTILITY(U,$J,358.3,18432,2)
 ;;=^87808
 ;;^UTILITY(U,$J,358.3,18433,0)
 ;;=425.9^^102^1181^7
 ;;^UTILITY(U,$J,358.3,18433,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18433,1,4,0)
 ;;=4^CMP SECONDARY,UNSPEC
 ;;^UTILITY(U,$J,358.3,18433,1,5,0)
 ;;=5^425.9
 ;;^UTILITY(U,$J,358.3,18433,2)
 ;;=^265123
 ;;^UTILITY(U,$J,358.3,18434,0)
 ;;=425.3^^102^1181^8
 ;;^UTILITY(U,$J,358.3,18434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18434,1,4,0)
 ;;=4^ENDOCARD FIBROELASTOSIS
 ;;^UTILITY(U,$J,358.3,18434,1,5,0)
 ;;=5^425.3
 ;;^UTILITY(U,$J,358.3,18434,2)
 ;;=^40296
 ;;^UTILITY(U,$J,358.3,18435,0)
 ;;=425.0^^102^1181^9
 ;;^UTILITY(U,$J,358.3,18435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18435,1,4,0)
 ;;=4^ENDOMYOCARDIAL FIBROSIS
 ;;^UTILITY(U,$J,358.3,18435,1,5,0)
 ;;=5^425.0
 ;;^UTILITY(U,$J,358.3,18435,2)
 ;;=^40494
 ;;^UTILITY(U,$J,358.3,18436,0)
 ;;=425.11^^102^1181^10
 ;;^UTILITY(U,$J,358.3,18436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18436,1,4,0)
 ;;=4^HYPERTROPHIC OBSTRUCTIVE
 ;;^UTILITY(U,$J,358.3,18436,1,5,0)
 ;;=5^425.11
 ;;^UTILITY(U,$J,358.3,18436,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,18437,0)
 ;;=496.^^102^1182^7
 ;;^UTILITY(U,$J,358.3,18437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18437,1,4,0)
 ;;=4^COPD
 ;;^UTILITY(U,$J,358.3,18437,1,5,0)
 ;;=5^496.
 ;;^UTILITY(U,$J,358.3,18437,2)
 ;;=COPD^24355
 ;;^UTILITY(U,$J,358.3,18438,0)
 ;;=491.8^^102^1182^6
 ;;^UTILITY(U,$J,358.3,18438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18438,1,4,0)
 ;;=4^BRONCHITIS CHR NEC
 ;;^UTILITY(U,$J,358.3,18438,1,5,0)
 ;;=5^491.8
 ;;^UTILITY(U,$J,358.3,18438,2)
 ;;=^87399
 ;;^UTILITY(U,$J,358.3,18439,0)
 ;;=493.22^^102^1182^1
 ;;^UTILITY(U,$J,358.3,18439,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18439,1,4,0)
 ;;=4^ASTHMA CH OBST W (AC) EXAC
 ;;^UTILITY(U,$J,358.3,18439,1,5,0)
 ;;=5^493.22
 ;;^UTILITY(U,$J,358.3,18439,2)
 ;;=^330090
 ;;^UTILITY(U,$J,358.3,18440,0)
 ;;=493.21^^102^1182^2
 ;;^UTILITY(U,$J,358.3,18440,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18440,1,4,0)
 ;;=4^ASTHMA CHR OBS W STAT ASTH
 ;;^UTILITY(U,$J,358.3,18440,1,5,0)
 ;;=5^493.21
 ;;^UTILITY(U,$J,358.3,18440,2)
 ;;=^269965
 ;;^UTILITY(U,$J,358.3,18441,0)
 ;;=493.20^^102^1182^3
 ;;^UTILITY(U,$J,358.3,18441,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18441,1,4,0)
 ;;=4^ASTHMA CHR OBST NOS
 ;;^UTILITY(U,$J,358.3,18441,1,5,0)
 ;;=5^493.20
 ;;^UTILITY(U,$J,358.3,18441,2)
 ;;=^330089
 ;;^UTILITY(U,$J,358.3,18442,0)
 ;;=494.1^^102^1182^4
 ;;^UTILITY(U,$J,358.3,18442,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18442,1,4,0)
 ;;=4^BRONCHIECTASIS W/ AC EXAC
 ;;^UTILITY(U,$J,358.3,18442,1,5,0)
 ;;=5^494.1
 ;;^UTILITY(U,$J,358.3,18442,2)
 ;;=^321991
 ;;^UTILITY(U,$J,358.3,18443,0)
 ;;=494.0^^102^1182^5
 ;;^UTILITY(U,$J,358.3,18443,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18443,1,4,0)
 ;;=4^BRONCHIECTASIS W/O AC EXAC
 ;;^UTILITY(U,$J,358.3,18443,1,5,0)
 ;;=5^494.0
 ;;^UTILITY(U,$J,358.3,18443,2)
 ;;=^321990
 ;;^UTILITY(U,$J,358.3,18444,0)
 ;;=492.8^^102^1182^8
 ;;^UTILITY(U,$J,358.3,18444,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18444,1,4,0)
 ;;=4^EMPHYSEMA NEC
 ;;^UTILITY(U,$J,358.3,18444,1,5,0)
 ;;=5^492.8
 ;;^UTILITY(U,$J,358.3,18444,2)
 ;;=^87569
 ;;^UTILITY(U,$J,358.3,18445,0)
 ;;=492.0^^102^1182^9
 ;;
 ;;$END ROU IBDEI11P
